Protective effect of ursodeoxycholic acid on COVID-19 in patients with chronic liver disease

OBJECTIVE: Ursodeoxycholic acid (UDCA) may reduce susceptibility to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection by downregulating angiotensin-converting enzyme 2 (ACE2), based on recent experimental investigation. This study aimed to determine the potential protective effe...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yanyan, Zhu, Na, Cui, Xinyu, Lin, Yingying, Li, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Cellular and Infection Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10189063/
https://www.ncbi.nlm.nih.gov/pubmed/37207192
http://dx.doi.org/10.3389/fcimb.2023.1178590

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10189063/
https://www.ncbi.nlm.nih.gov/pubmed/37207192
http://dx.doi.org/10.3389/fcimb.2023.1178590

Ejemplares similares